More details of a proposed $11 million-a-year ‘Neovascular AMD treatment incentive program’ that would financially encourage more ophthalmologists to bulk...
Read moreDetailsMelbourne biopharmaceutical company Opthea has abandoned efforts to develop its therapy sozinibercept for neovascular age-related macular degeneration (nAMD), with a...
Read moreDetailsResearchers at the National Institutes of Health (NIH) in the United States say they have developed eye drops that extend...
Read moreDetailsMelbourne biopharmaceutical firm Opthea has failed to meet the primary end point in a pivotal Phase 3 trial of its...
Read moreDetailsOptos will have a strong presence on the Australian ophthalmic events circuit in 2025, providing a key opportunity for eyecare...
Read moreDetailsThe Federal Government is deferring the controversial private health insurance reclassification of intravitreal injections for another 12 months and will...
Read moreDetailsIn what is expected to be great news for about 20,000 Australians, ophthalmologists are now able to prescribe the first...
Read moreDetailsMacular Disease Foundation Australia (MDFA) is calling on the next Federal Government to allow bulk billing of eye injections for...
Read moreDetailsApproval of the first therapy for geographic atrophy (GA), Syfovre (pegcetacoplan), is being hailed a “landmark moment” for the the...
Read moreDetailsFour eye research projects have secured more than $8 million in funding in the 2025 National Health and Medical Research...
Read moreDetailsInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited